Nanowear Announces Continuous Glucose Monitoring (CGM) Licensing and Data Partnership With Dexcom

NEW YORK--(BUSINESS WIRE)--Mar 25, 2025--

Nanowear, a leader in home-based cardiometabolic digital diagnostics announced that SimpleSense™, a nanotechnology-enabled wearable, mobile and software diagnostics platform, will ingest glucose data from Dexcom G7 Continuous Glucose Monitoring Systems (CGM) time synchronously alongside Nanowear’s previously FDA cleared cardiovascular biomarkers. The continuous combination of glucose readings, blood pressure, ECGs, lung volume, respiration and hemodynamics offer unprecedented real-world and real-time cardiometabolic diagnostic assessments to the pharmaceutical, medtech, biotech, contract-research-organization (CRO) and direct-to-consumer (DTC) research communities.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250325067625/en/

“Our Nanowear-Dexcom integration and data partnership will be a unique offering in clinical research,” says Venk Varadan, CEO and Co-founder of Nanowear. “With the addition of CGM, our platform of 85+ cardiopulmonary and hemodynamic biomarkers now becomes the first-and-only self-administered cardiometabolic assessment of 9 combinatorial, time synchronous diagnostic tools and structured data channels through a single app, iOS or Android. There is high demand in the CRO and DTC research communities for a true home-based cardiometabolic assessment that can be self-administered – sponsors want to uncover novel correlative diagnostics utilizing our proven AI approaches in cardiometabolic health.”

Cardiometabolic health is defined as the combination of risk factors for cardiovascular disease. Cardiometabolic conditions such as obesity, diabetes and hypertension are the leading causes of death and illness in the United States and recent studies have shown that since 1999, only 6.8% of Americans have optimal cardiometabolic health. “Quantifying cardiometabolic health with real-world evidence is swiftly becoming the new frontier in cardiovascular research,” says Ami Bhatt MD, Chief Innovation Officer at American College of Cardiology (ACC). “This ability to measure and understand these relationships moves us closer towards early diagnosis and individualized preventative care.”

With expanding indications for cardiometabolic therapeutics such as GLP-1s and renal denervation, the pharmaceutical, medtech, biotech and direct-to-consumer research communities are seeking novel assessment and diagnostic solutions to understand the safety and efficacy of their products in terms of cardiometabolic effects.

“Therapeutics or devices in the Phase II or Phase III research phase constantly affect blood sugar levels and blood pressure levels,” says Mehdi Adineh, VP of Core Labs Innovation at Medpace (NSDQ: MEDP), one of the world’s leading pharmaceutical and biotech CROs. “Our sponsors as well as FDA seek a deeper understanding of these effects in sub-population analyses while clinical trial participants are at home, as opposed to analyses from in-person assessments with 9 traditional diagnostic tools that are not continuous or real world. New technologies like Nanowear can accelerate pharmaceutical and biotechnology companies’ insights into individualized safety and effectiveness of their next-generation therapies.”

Nanowear’s Varadan is speaking at ACC Scientific Sessions 2025 in Chicago, IL on March 30 entitled “Accelerating Innovation in Cardiology”.

ABOUT NANOWEAR, INC
Nanowear is a leading healthcare-at-home digital diagnostics company providing a smarter way to collect and analyze cardiometabolic data through real-world evidence. Its end-to-end software, mobile, and AI-powered platform is a radical leap forward in clinical research and virtual care, empowering physician decision-making with scored, clinical-grade diagnostics through patented nanotechnology and AI diagnostics ultimately providing early diagnosis and precision medicine. To learn more, visit www.nanowearinc.com.

ABOUT DEXCOM, INC
Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently. Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.

ABOUT THE AMERICAN COLLEGE OF CARDIOLOGY (ACC)
ACC is the global leader in transforming cardiovascular care and improving heart health for all. As the preeminent source of professional medical education for the entire cardiovascular care team since 1949, ACC credentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. Through its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at www.ACC.org or follow @ACCinTouch.

ABOUT MEDPACE, INC
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,900 people across 44 countries as of December 31, 2024. To learn more, visit www.medpace.com.

Nanowear Announces Continuous Glucose Monitoring (CGM) Licensing and Data Partnership With Dexcom

PROVIDENCE, R.I. (AP) — A man who is suspected of killing two and wounding several others at Brown University has been found dead in a New Hampshire storage facility where he had rented a unit, officials said.

Claudio Neves Valente, 48, a former Brown student and Portuguese national, was found dead Thursday evening from a self-inflicted gunshot wound, Col. Oscar Perez, the Providence police chief, said at a news conference. Perez said as far as investigators know, the suspect acted alone.

Investigators believe Valente is responsible for both the shooting at Brown and the killing of a Massachusetts Institute of Technology professor who was fatally shot in his Brookline home Monday, a law enforcement official told The Associated Press. Authorities have not formally confirmed a connection between the two shootings.

The official could not publicly discuss details of the ongoing investigation and spoke to AP on condition of anonymity.

Brown University President Christina Paxson said Valente was enrolled at Brown from the fall of 2000 to the spring of 2001. He was admitted to the graduate school to study physics beginning in September 2000. “He has no current affiliation with the university," she said.

Two people were killed and nine were wounded in the mass shooting Saturday at Brown University. The investigation had shifted Thursday when authorities said they were looking into a connection between the Brown mass shooting and an attack two days later near Boston that killed MIT professor Nuno F.G. Loureiro.

The FBI previously said it knew of no links between the cases.

A second individual who was identified in proximity to the suspect came forward after Wednesday’s press conference and helped “blow the lid” off the case, Rhode Island Attorney General Peter Neronha said.

“When you crack it, you crack it. That person led us to the car, led us to the name," Neronha said.

Neronha said there are still “a lot of unknowns” in regard to motive. “We don’t know why now, why Brown, why these students and why this classroom,” he said.

Frustration had mounted in Providence that the person behind the attack managed to get away and that a clear image of their face hadn’t emerged.

Although Brown officials say there are 1,200 cameras on campus, the attack happened in an older part of the engineering building that has few, if any, cameras. And investigators believe the shooter entered and left through a door that faces a residential street bordering campus, which might explain why the cameras Brown does have didn’t capture footage of the person.

In such targeted and highly public attacks, the shooters typically kill themselves or are killed or arrested by police, said Katherine Schweit, a retired FBI agent and expert on mass shootings. When they do get away, searches can take time.

In the 2013 Boston Marathon bombing, it took investigators four days to catch up to the two brothers who carried it out. In a 2023 case, Army reservist Robert Card was found dead of an apparent suicide two days after he killed 18 people and wounded 13 others in Lewiston, Maine.

The man accused of killing conservative political figure Charlie Kirk in September turned himself in about a day and a half after the attack on Utah Valley University's campus. And Luigi Mangione, who has pleaded not guilty to murder charges in the killing of UnitedHealthcare CEO Brian Thompson in Manhattan last year, was arrested five days later at a McDonald's in Pennsylvania.

Loureiro, who was married, joined MIT in 2016 and was named last year to lead the school's Plasma Science and Fusion Center, where he worked to advance clean energy technology and other research. The center, one of MIT's largest labs, had more than 250 people working across seven buildings when he took the helm. He was a professor of physics and nuclear science and engineering.

He grew up in Viseu, in central Portugal, and studied in Lisbon before earning a doctorate in London, according to MIT. He was a researcher at an institute for nuclear fusion in Lisbon before joining MIT, the university said.

“He shone a bright light as a mentor, friend, teacher, colleague and leader, and was universally admired for his articulate, compassionate manner,” Dennis Whyte, an engineering professor who previously led MIT’s Plasma Science and Fusion Center, told a campus publication.

Loureiro had said he hoped his work would shape the future.

“It’s not hyperbole to say MIT is where you go to find solutions to humanity’s biggest problems,” Loureiro said when he was named to lead the plasma science lab last year. “Fusion energy will change the course of human history.”

This story was updated to delete a reference to MIT being an Ivy League school.

Richer and Tucker reported from Washington. Associated Press reporters Mark Scolforo in Harrisburg, Pennsylvania, and Hallie Golden in Seattle contributed.

People gather outside a storage facility where a suspect in the shooting at Brown University was found dead, Thursday, Dec. 18, 2025, in Salem, N.H. (AP Photo/Reba Saldanha)

Law enforcement officers are seen outside a storage facility where a suspect in the shooting at Brown University was found dead, Thursday, Dec. 18, 2025, in Salem, N.H. (AP Photo/Reba Saldanha)

Law enforcement officers search the area for the Brown University shooting suspect, Thursday, Dec. 18, 2025, in Salem, N.H. (AP Photo/Reba Saldanha)

A pedestrian walks along Brown University's campus on Thayer St. in Providence, R.I., Wednesday, Dec. 17, 2025. (Lily Speredelozzi/The Sun Chronicle via AP)

This image taken from video provided by the FBI shows a person of interest in the investigation of the shooting that occurred at Brown University, in Providence, R.I., Saturday, Dec. 13, 2025. (FBI via AP)

A poster seeking information about the campus shooting suspect is seen on the campus of Brown University, Wednesday, Dec. 17, 2025, in Providence, R.I. (AP Photo/Robert F. Bukaty)

A woman lights a candle at a memorial set up in front of the Barus and Holley engineering building at Brown University in Providence, RI, Thursday, Dec. 18, 2025. (AP Photo/ Mark Stockwell)

A Brown University student walks past a church on the Providence, RI, campus, Thursday, Dec. 18, 2025. (AP Photo/ Mark Stockwell)